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European Commission and Patients Associations identify
Registries as strategic instruments to improve knowledge
in the field of Rare Diseases [1,2]. Interoperability between
Rare Diseases Patient Registries (RDPR) is especially
needed to support research activities, to validate thera-
peutic treatments and to plan public health actions.
Because of the extreme variety of RDPR, a uniform and
standardized way of collecting data and the identification
of specific levels of connection between RDPR with similar
aims is needed.
In this study, exploratory data analyses were applied
to the EPIRARE (European Platform for Rare Diseases
Registries) Registry Survey in order to generate a macro-
classification and characterization of RDPR and to deepen
different informative needs.
At first, a Multiple Correspondence Analysis (MCA)
suggested associations between selected variables charac-
terizing the structure of RDPR (Figure 1). Then, a Cluster
analysis (CA) was developed using the declared “Aims” of
each RDPR. CA confirmed the variable associations
emerged by MCA and identified three groups defined as:
Public Health (PHR), Clinical-Genetic Research (CGRR),
and Treatment Registries (TR). Finally, the random forest
(RF) method was applied to the Survey data, leading to six
classification models endowed of good predictive power
and thus confirming the reliability of considering three
groups of RDPR. RF also identified several informative
variables which allowed the characterization of the three
categories of RDPR, defined by data of different nature
and by different levels of diffusion (Table 1).
These results, identifying different profiles of RDPR
and specific informative needs, represent an informative
support aimed at addressing the activities for the design
of an European platform of Rare Diseases. Identification
of informative cores could address the activities of a
platform able to enhance the sharing of information
between RDPR with common aims, but also to facilitate
a coherent dialogue between RDPR with different
profiles.
Guide to interpretation: the arrows indicate the direc-
tions of association among the aims; the dimension of
the circles represents the frequency of the variable. The
higher are the coordinate and the frequency of the vari-
able, the more it contributes to the interpretation of the
factorial axis; variables placed on the same direction are
correlated.
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Figure 1 Factorial plan by MCA.
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Table 1 Main characteristics of Clinical-Genetic Research, Treatment, and Public Health Registries according to the
most informative variables emerged after the random forest method. Variables reported in the table characterize
most of the registries of each class.
Variables Public Health Registries Treatment Registries Clinical-Genetic research
Registries








-natural history of the disease
Collected data socio-demographic - clinical
- medications, devices and health services
- genetic
- family history
- date of the patient death





Coding system ICD No coding system or own code No coding system or own code
Services requested to a EU
platform
“Quality control systems” “Facilitated access to useful data sources” “Model documents”
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